Entries by awp-admin

Dr. Robert Schwartz Invited to Serve As IAS-NIDA Fellowship Mentor

FRI is pleased to announce that its Medical Director, Robert Schwartz, M.D., was recently invited to serve as a mentor for the IAS-NIDA International Fellowship Program. Prospective fellows will be able to choose a mentor in their field of interest and contact the mentor to discuss the possibility of working on a specific research project. […]

FRI Named Top Workplace 2012

Friends Research Institute was recently named to the list of “The Baltimore Sun Top Workplaces” for 2012. This is FRI’s second year in a row for making the list. The evaluation for the Top Workplaces program continues to be based upon feedback from employee surveys, of which FRI received high ratings from its employees. FRI […]

New Senior Research Scientist Joins FRI

FRI is pleased to announce that Dr. Jami Obermayer, formerly the Director of Research at PICS, Inc., has accepted a position as a Senior Research Scientist at FRI. Dr. Obermayer has been conducting small business innovation research for the past nine years and has been the Principal Investigator for projects focused on health-related behaviors, including […]

FRI Researcher Receives HRSA SPNS Grant Award

FRI is pleased to announce that Cathy J. Reback, Ph.D. was awarded a HRSA SPNS grant entitled, “Enhancing Linkages to and Retention in HIV Primary Care for Transgender Women of Color: The Alexis Project.” Transwomen of color experience a number of psychosocial challenges including discrimination, prejudice, stigmatization, and social/economic marginalization, which stand as obstacles to […]

New Research Scientist Joins FRI

FRI is pleased to announce that Dr. Erica Peters has accepted a position as an Assistant Research Scientist at FRI. Dr. Peters is a clinical psychologist specializing in treatment efficacy, human laboratory, and natural history studies for marijuana and tobacco cessation. Her research aims are to: (1) enhance behavioral interventions for marijuana dependence, (2) identify […]

FRI Employee, Jan Gryczynski, Awarded Doctoral Degree

FRI is pleased to announce that Jan Gryczynski, Research Scientist at FRI, recently received his Ph.D. in Public Policy from the University of Maryland, Baltimore County. For his doctoral research, Dr. Gryczynski conducted a national study of on-site HIV testing in nearly 10,000 substance abuse treatment programs across the United States. His research employed multilevel […]

FRI Researcher Receives First R01 Award

FRI is pleased to announce that Shannon Gwin Mitchell, Ph.D., along with Co-Investigators Robert Schwartz and Barry Brown, have received a grant award from the National Institute on Drug Abuse entitled “SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers.” The proposed study is significant because it will help determine whether one adolescent Screening, […]

FRI Welcomes Dr. Melicia Whitt-Glover as an Affiliated Senior Research Scientist

Dr. Whitt-Glover is President and CEO of Gramercy Research Group in Winston-Salem, North Carolina. She is a community-based researcher with background, training, and experience in exercise science and epidemiology. Her research activities include developing and assessing interventions to increase physical activity in racial/ethnic minority communities. FRI researchers look forward to collaborating with Dr. Whitt-Glover on […]

NPR article: Dr. Jerome Jaffe’s study, The Connection Between New Year’s Resolutions and a Landmark Study Regarding Heroin Addiction Among Returning Vietnam War Veterans

Read a 2012 NPR article that refers to FRI Senior Research Scientist, Dr. Jerome Jaffe, about a connection between New Year’s Resolutions and the landmark study about heroin addiction among returning Vietnam War veterans commissioned by Dr. Jaffe and led by the late Dr. Lee Robins. [ What Vietnam Taught Us About Breaking Bad Habits ]

Dr. Thomas Hanlon, Senior Research Scientist, Retires After a 52-Year Relationship with FRI

Dr. Thomas Hanlon has had a long and distinguished career in the areas of personality assessment and treatment evaluation. His initial research experience involved conducting clinical psychopharmacological trials largely involving the treatment of schizophrenic and other seriously ill psychiatric patients. During this same period, he also participated in early treatment evaluation studies of the effectiveness […]